Ultragenyx Pharmaceutical Inc. has announced the grant of 45,292 restricted stock units to 29 newly hired non-executive officers as part of the Ultragenyx Employment Inducement Plan. Approved by the company's compensation committee, the grants were issued on July 16, 2025, in compliance with Nasdaq Listing Rule 5635(c)(4). These restricted stock units are set to vest over a four-year period, with 25% of the shares vesting annually on the anniversary of the grant date, contingent upon the employees' continuous employment with the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.